rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCAGGGACAGGGCGAATCGGCTACACCTTCGGTTCG	CASSVAGTGRIGYTF	In	VDJ	1	21	0.0026926529042184894	0.003289473684210526	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	8	2	6	23	39	50	41	56			01,02										Vb 1	CASSVAGTGRIGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGATCTCCAGGGGCCGGAGAAAAACTGTTTTTTGGCAGT	CASSQGSPGAGEKLFF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	2	8	6	5	29	45	57	51	62													Vb 16	CASSQGSPGAGEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGCCGAGCCAGGGACAGTCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	0.0017951019361456598		49	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	2	9	2	29	42	58	51	60													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTAGGGGAAGAGAAGGGAGGGTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	0.003333760738556225		50	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	9	0	5	14	1	29	42	63	56	64													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACTACAGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSQLQGGTEAFF	In	VDJ	2	41	0.005257084241569432	0.006422305764411027	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	1	4	2	1	29	44	54	46	55													Vb 16	CASSQLQGGTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGTGGGGGACCCAGTACTTCGGGCCA	CASSQEWGTQYF	In	VDJ	2	58	0.007436850878317733	0.009085213032581453	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	0	6	2	7	2	0	29	46	-1	48	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQEWGTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCGGACAGCTGAAAAACTGTTTTTTGGCAGT	CASSRTAEKLFF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	5	7	2	1	24	35	43	37	44														CASSRTAEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAGCTGGATGCTTAAGGACATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASKLDA*GHE*KTYGYTF	Stop	VDJ	1	11	0.0014104372355430183		57	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	1	6	4	17	12	24	31	53	48	65														CASKLDA*GHE*KTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAACAGCGCACAGATACGCAGTATTTTGGCCCA	CASSVEQRTDTQYF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	5	1	5	1	24	36	45	41	46														CASSVEQRTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTGGGACCTACAGGGGATGGCTACACCTTCGGTTCG	CASSLGPTGDGYTF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	2	6	10	0	24	35	-1	45	52														CASSLGPTGDGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCATCATGGTTCCGGCGGGTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	18	0.002307988203615848		46	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	7	4	4	14	1	24	31	50	45	51						01,02								X+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGGGGGGTACTGAAGCTTTCTTTGGACAA	CASSAGGTEAFF	In	VDJ	1	19	0.0024362097704833953	0.002976190476190476	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	1	5	0	1	24	-1	44	36	45														CASSAGGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAAGCGAACAGGTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	0.0026926529042184894		43	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	4	3	5	2	24	39	49	44	51														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCAGGGTTGTTGAACACTGAAGCTTTCTTTGGACAA	CASSPGLLNTEAFF	In	VDJ	1	24	0.003077317604821131	0.0037593984962406013	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	0	1	4	24	36	42	37	46														CASSPGLLNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCATCGGGACAGGGGGCCACAATGAGCAGTTCTTCGGGCCA	CASSIGTGGHNEQFF	In	VDJ	2	56	0.007180407744582639	0.008771929824561403	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	0	5	2	1	24	37	51	39	52														CASSIGTGGHNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGATGACCGGGACAGGGGCGTTAACTATGGCTACACCTTCGGTTCG	CASSDDRDRGVNYGYTF	In	VDJ	3	86	0.011027054750609052	0.013471177944862155	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	1	8	3	24	35	53	43	56														CASSDDRDRGVNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCTTTTTGGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSFFLGGTGELFF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	9	1	4	6	0	18	32	-1	38	44														CASSFFLGGTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGAGCTAGCGGGGGGGCGCGATACGCAGTATTTTGGCCCA	CASSLELAGGRDTQYF	In	VDJ	1	21	0.0026926529042184894	0.003289473684210526	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	0	6	4	3	18	32	48	36	51														CASSLELAGGRDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCTAGGGACAGGGGACTACGAGCAGTACTTCGGGCCG	CASSLGTGDYEQYF	In	VDJ	2	54	0.006923964610847545	0.008458646616541353	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	2	3	0	1	18	-1	43	34	44														CASSLGTGDYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCGCAGTCCCCCACAGTCTTTACGAGCAGTACTTCGGGCCG	CASSAVPHSLYEQYF	In	VDJ	1	12	0.0015386588024105655	0.0018796992481203006	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	5	4	10	4	19	31	45	41	49														CASSAVPHSLYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCCACGGGGGGGAAAGCCTACGAGCAGTACTTCGGGCCG	CASSPTGGKAYEQYF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	0	2	4	4	19	31	43	35	47														CASSPTGGKAYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCTGGATGCCGGGAAAATAATGAAAAACTGTTTTTTGGCAGT	CASSSGCRENNEKLFF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	8	3	4	8	3	19	32	45	40	48													Vb 5.1	CASSSGCRENNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTTTGAGACAGGGGCCACTAGGACCCTCCACTTTGGGAAC	CASSLFETGATRTLHF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	2	2	14	5	9	19	34	47	39	56													Vb 5.1	CASSLFETGATRTLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACGACGACAGGGTGATTCTGAATGGCTACACCTTCGGTTCG	CASSLDDDRVILNGYTF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	6	5	9	19	35	47	40	56													Vb 5.1	CASSLDDDRVILNGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGATCGGGGTTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	0.0017951019361456598		40	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	3	6	2	1	19	35	42	37	43													Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCAACGGACAGGGGTAATTCACCCCTCCACTTTGGGAAC	CASSLATDRGNSPLHF	In	VDJ	1	15	0.0019233235030132068	0.002349624060150376	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	1	2	6	4	0	19	35	-1	39	48													Vb 5.1	CASSLATDRGNSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCAACCGACGGACAGGGGTTTAGGACCCAGTACTTCGGGCCA	CASSSTDGQGFRTQYF	In	VDJ	1	24	0.003077317604821131	0.0037593984962406013	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	2	7	8	5	19	32	49	40	54													Vb 5.1	CASSSTDGQGFRTQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCAGACATCTATGTACCTCTGTGCCAGCAGTGGATTTTATCCGGACAGGGGTCTGTCATGGTCCTACGAGCAGTACTTCGGGCCG	CASSGFYPDRGLSWSYEQYF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	60	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	1	11	10	21	33	53	44	63													Vb 3	CASSGFYPDRGLSWSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGATCAGGTGGAAACACCATATATTTTGGAGAG	CASSRSGGNTIYF	In	VDJ	1	25	0.003205539171688678	0.003916040100250626	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	4	3	5	0	25	36	-1	41	45													Vb 3	CASSRSGGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAGAACACTGAAGCTTTCTTTGGACAA	CASSLENTEAFF	In	VDJ	1	30	0.0038466470060264137	0.004699248120300752	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	2	8	1	0	0	25	-1	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLENTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACGCTTTTACTTGACACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	37	0.0047441979740992435		56	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	6	5	12	7	25	38	54	50	61													Vb 3	X+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTTTGGGGACCTGAAGCTTTCTTTGGACAA	CSVEVWGPEAFF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	1	0	7	6	4	0	25	38	-1	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEVWGPEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACCATAAGAAGGCAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	13	0.0016668803692781126		41	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-04	01	3	5	4	5	8	1	25	36	47	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01		TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGACAGGGTTCGGAAGGCTACACCTTCGGTTCG	CSVGQGSEGYTF	In	VDJ	1	15	0.0019233235030132068	0.002349624060150376	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	8	0	7	25	-1	42	35	49													Vb 4	CSVGQGSEGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGACAGACAGGGGAACACAGATACGCAGTATTTTGGCCCA	CSADRQGNTDTQYF	In	VDJ	1	18	0.002307988203615848	0.002819548872180451	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	2	2	2	6	2	25	32	46	38	48													Vb 4	CSADRQGNTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATTCTGGGACCCAAGAGACCCAGTACTTCGGGCCA	CSVEDSGTQETQYF	In	VDJ	1	19	0.0024362097704833953	0.002976190476190476	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	0	0	7	1	4	0	25	39	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDSGTQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGGAGGACAGAGAAGCTTTCTTTGGACAA	CSVEEEDREAFF	In	VDJ	1	31	0.003974868572893961	0.004855889724310777	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	5	8	3	1	25	39	48	42	49													Vb 4	CSVEEEDREAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTCGGACAGGGCGAGCTAACTATGGCTACACCTTCGGTTCG	CSARTGRANYGYTF	In	VDJ	3	66	0.00846262341325811	0.010338345864661654	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	3	0	3	4	25	32	43	35	47													Vb 4	CSARTGRANYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTATAGGACAGTTTGGAAAACTGTTTTTTGGCAGT	CSVIGQFGKLFF	In	VDJ	9	228	0.029234517245800742	0.03571428571428571	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	5	10	3	5	25	34	43	37	48													Vb 4	CSVIGQFGKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAGGACAGTGGGATACGCAGTATTTTGGCCCA	CASSEGQWDTQYF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	5	6	1	3	23	37	44	38	47													Vb 12	CASSEGQWDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTTAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSELGGYEQYF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	5	1	3	1	0	23	39	-1	40	46													Vb 12	CASSELGGYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCCCCAGTATGTGAAGGATTTACGGTATGGCTACACCTTCGGTTCG	CASPQYVKDLRYGYTF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	48	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	8	1	8	5	14	7	23	32	49	46	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASPQYVKDLRYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCAGTCAGGGGGCTATCAGCCCCAGCATTTTGGTGAT	CASSQSGGYQPQHF	In	VDJ	1	11	0.0014104372355430183	0.0017230576441102756	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	0	5	0	1	23	-1	47	40	48													Vb 12	CASSQSGGYQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGGAAGGGACTATGGCTACACCTTCGGTTCG	CASRGRDYGYTF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	36	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	6	0	8	3	0	4	23	-1	38	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRGRDYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGACTAGGACAGAGGAACACTGAAGCTTTCTTTGGACAA	CASRLGQRNTEAFF	In	VDJ	1	17	0.002179766636748301	0.002662907268170426	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	1	4	2	23	34	44	38	46													Vb 12	CASRLGQRNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCCCAGACATCTGTGTATTTCTGCGCCAGCAAGATAAAGAGGGGCCGTACCCCATCGGACTCTGGAAACACCATATATTTTGGAGAG	CASKIKRGRTPSDSGNTIYF	In	VDJ	1	22	0.0028208744710860366	0.003446115288220551	60	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-03	01	7	5	2	0	8	15	21	31	44	39	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASKIKRGRTPSDSGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01		TCRBJ01-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGGTATCGGCGGAGGCACAGATACGCAGTATTTTGGCCCA	CASGIGGGTDTQYF	In	VDJ	2	43	0.005513527375304526	0.006735588972431077	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	7	5	1	7	2	23	32	43	39	45						01,02							Vb 12	CASGIGGGTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTACGGGACTAGCGGGGGTACTGGGAGAGCAGTTCTTCGGGCCA	CAISESTGLAGVLGEQFF	In	VDJ	1	17	0.002179766636748301	0.002662907268170426	54	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	0	2	10	3	8	23	40	57	43	65													Vb 12	CAISESTGLAGVLGEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCACAGGGGGCGGACAGCCCTAGCATTTTGGTGAT	CASSIGTGGGQP*HF	Stop	VDJ	1	8	0.001025772534940377		45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	0	14	2	10	27	43	54	45	64			01,02										Vb 17	CASSIGTGGGQP*HF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCGGTCAGGAGGGGATATGGCTACACCTTCGGTTCG	CASAVRRGYGYTF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	8	10	0	5	7	2	27	36	49	43	51			01,02										Vb 17	CASAVRRGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGACAGACTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLTDSYNSPLHF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	5	0	2	1	27	39	46	41	47			01,02										Vb 17	CASSLTDSYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAAGGTGGGGACCGGGGAGCTGTTTTTTGGAGAA	CATKVGTGELFF	In	VDJ	1	15	0.0019233235030132068	0.002349624060150376	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	10	6	2	5	7	0	27	34	-1	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATKVGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGACAATTCTTAAGGCTGAAGCTTTCTTTGGACAA	CASSKTILKAEAFF	In	VDJ	1	15	0.0019233235030132068	0.002349624060150376	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	6	6	1	10	27	40	45	41	55			01,02										Vb 17	CASSKTILKAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCACCAGAGCCAAGAGACCCAGTACTTCGGGCCA	CASSIHQSQETQYF	In	VDJ	1	20	0.0025644313373509426	0.003132832080200501	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	4	5	1	4	2	27	41	48	45	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIHQSQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTTGGGACAGGGGCTTGAAGCTTTCTTTGGACAA	CASSLGQGLEAFF	In	VDJ	1	22	0.0028208744710860366	0.003446115288220551	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	7	3	2	27	38	51	41	53			01,02										Vb 17	CASSLGQGLEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGAGGATTTCTAGGTCTACTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGGFLGLLNTGELFF	In	VDJ	1	25	0.003205539171688678	0.003916040100250626	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	10	1	2	0	16	27	-1	44	39	60			01,02										Vb 17	CASSGGFLGLLNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGCGGGGTTCTCCTACGAGCAGTACTTCGGGCCG	CASSPAGFSYEQYF	In	VDJ	2	38	0.004872419540966791	0.005952380952380952	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	6	3	0	2	2	27	39	48	41	50			01,02										Vb 17	CASSPAGFSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGACGGGGTGTACAATGAGCAGTTCTTCGGGCCA	CASSPDGVYNEQFF	In	VDJ	2	38	0.004872419540966791	0.005952380952380952	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	3	4	5	2	27	39	49	44	51			01,02										Vb 17	CASSPDGVYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGCAACAGGGGGCGGGAGATACGCAGTATTTTGGCCCA	CASSTQQGAGDTQYF	In	VDJ	2	46	0.005898192075907168	0.0072055137844611525	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	0	5	4	3	27	40	53	44	56			01,02										Vb 17	CASSTQQGAGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTATTAGCGACAAATCACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	47	0.006026413642774715		55	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	5	6	5	4	14	26	38	47	42	61			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01	TCRBJ02-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACCTGATAGGGGGTTGTCAAAAACATTCAGTACTTCGGCGCC	CASRT**GVVKNIQYF	Stop	VDJ	2	50	0.006411078343377356		48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	5	1	3	8	4	27	38	52	46	56			01,02										Vb 17	CASRT**GVVKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGTCGGAGCGAGCTCCTACGAGCAGTACTTCGGGCCG	CASVGASSYEQYF	In	VDJ	5	135	0.01730991152711886	0.021146616541353382	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	6	6	0	5	2	27	36	45	41	47			01,02			01,02							Vb 17	CASVGASSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCTACGATCTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	8	0.001025772534940377		38	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	4	9	6	1	5	23	33	37	34	42						01,02							Vb 11	X+TCRBV25-01+TCRBJ01-06	TCRBV25-01*01	TCRBD02-01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCCTTAGGTATAACTGGGAAAGACCTATGGCTACACCTTCGGTTCG	CASSP*V*LGKTYGYTF	Stop	VDJ	1	10	0.0012822156686754713		51	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	5	0	8	4	14	5	23	35	53	49	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSP*V*LGKTYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGAACGGACAGGAAACACCATATATTTTGGAGAG	CASSEERTGNTIYF	In	VDJ	2	37	0.0047441979740992435	0.005795739348370927	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	6	4	4	0	23	38	-1	42	47													Vb 11	CASSEERTGNTIYF+TCRBV25-01+TCRBJ01-03	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCCGGGACAGCATGACCTACGAGCAGTACTTCGGGCCG	CASRDSMTYEQYF	In	VDJ	2	38	0.004872419540966791	0.005952380952380952	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	5	2	1	5	23	32	40	33	45													Vb 11	CASRDSMTYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGGGACTAGCATTACCGGGGAGCTGTTTTTTGGAGAA	CASGTSITGELFF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	0	7	5	0	3	23	-1	41	32	44						01,02							Vb 22	CASGTSITGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGTTTCCCGGACAGGGACCGAGACCCAGTACTTCGGGCCA	CASSEVSRTGTETQYF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	5	10	3	26	38	56	48	59														CASSEVSRTGTETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGTTGGGATTCGGGAAAAACTGTTTTTTGGCAGT	CASSLVGIREKLFF	In	VDJ	1	18	0.002307988203615848	0.002819548872180451	42	TCRBV07	TCRBV07-07	01				TCRBJ01	TCRBJ01-04	01	1	0	8	8	2	5	19	35	41	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGIREKLFF+TCRBV07-07+TCRBJ01-04	TCRBV07-07*01		TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCTATGCCGGGACAGGGGAAGGGCTGTTTTTTGGCAGT	CASSYAGTGEGLFF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	2	14	5	5	19	32	47	37	52		TCRBV07-02,TCRBV07-05												CASSYAGTGEGLFF+TCRBV07-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CTCCCTCCCARACATCTGTRTACTTCTGTGCCAGCAGTTACGATACAGGGAGAGAGACCCAGTACTTCGGGCCA	CASSYDTGRETQYF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	3	4	3	2	25	40	49	43	51		TCRBV06-02,TCRBV06-03,TCRBV06-09												CASSYDTGRETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCCGCCAGCTGGCAGCGGGGGGGCCTCGAGGCAATGAGCAGTTCTTCGGGCCA	CASRQLAAGGPRGNEQFF	In	VDJ	1	15	0.0019233235030132068	0.002349624060150376	54	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	6	0	6	11	8	27	36	57	47	65		TCRBV06-04,TCRBV06-08												CASRQLAAGGPRGNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCTTGGCCCGAAACTCCAGAGACCCAGTACTTCGGGCCA	CASSSWPETPETQYF	In	VDJ	1	16	0.002051545069880754	0.002506265664160401	45	TCRBV06	unresolved					TCRBJ02	TCRBJ02-05	01	4	9	0	4	3	10	26	39	45	42	55		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSWPETPETQYF+TCRBV06-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTTGGAGGGCTCGCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	20	0.0025644313373509426		52	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	10	0	5	1	13	26	38	45	39	58		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTTCGGGACAGGGGGCGCGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSFGTGGASTGELFF	In	VDJ	1	20	0.0025644313373509426	0.003132832080200501	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	0	4	2	5	26	39	53	41	58		TCRBV06-07,TCRBV06-08												CASSFGTGGASTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGGSGACTCRGCTGTGTATCTCTGTGCCAGCAGCTTTCCCGGGACAGAGTCAGATACGCAGTATTTTGGCCCA	CASSFPGTESDTQYF	In	VDJ	1	25	0.003205539171688678	0.003916040100250626	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	5	4	4	3	22	36	47	40	50		TCRBV07-04,TCRBV07-05												CASSFPGTESDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGACACGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSETRNTGELFF	In	VDJ	1	27	0.0034619823054237724	0.0042293233082706765	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	6	1	0	2	26	-1	44	41	46		TCRBV10-01,TCRBV10-02												CASSETRNTGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCTAGGGGCGGACCTGCCTGAAGCTTTCTTTGGACAA	CASSLGADLPEAFF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	2	6	3	9	26	37	45	40	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLGADLPEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATTACAGGGACCCACTGAAGCTTTCTTTGGACAA	CASSLLQGPTEAFF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	4	2	3	26	41	49	43	52		TCRBV12-03,TCRBV12-04												CASSLLQGPTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGAGGGGGAGACCCAGTACTTCGGGCCA	CASSQVEGETQYF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	10	0	5	1	1	26	42	49	43	50		TCRBV03-01,TCRBV03-02												CASSQVEGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTACAGGAAATCCGTATAATGAGCAGTTCTTCGGGCCA	CASSQVTGNPYNEQFF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	3	4	7	2	10	26	42	49	44	59		TCRBV03-01,TCRBV03-02												CASSQVTGNPYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTGCCGGGTTACTCCTACGAGCAGTACTTCGGGCCG	CSASLPGYSYEQYF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	4	0	5	3	26	37	46	42	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASLPGYSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATGGAGGGGCAGGGGGTCAGCCCCAGCATTTTGGTGAT	CASSQDGGAGGQPQHF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	1	6	8	0	23	40	-1	48	55	TCRBV01,TCRBV04													CASSQDGGAGGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTTGGCGGGACCATCGGCCAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSWRDHRPGSYEQYF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	7	3	1	1	13	22	35	42	36	55	TCRBV09,TCRBV12													CASSWRDHRPGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTAGGGACGAACCGCTATGGCTACACCTTCGGTTCG	CASSLGTNRYGYTF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	42	unresolved						TCRBJ01	TCRBJ01-02	01	6	0	7	4	4	6	20	31	40	35	46	TCRBV11,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTNRYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTGGACTAGCGGGGGGGCAAGCGACAGATACGCAGTATTTTGGCCCA	CASSFGLAGGQATDTQYF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	1	0	3	1	6	19	33	49	34	55	TCRBV05,TCRBV11													CASSFGLAGGQATDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTAAATTCACAGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSLNSQPYNEQFF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	5	2	5	1	22	37	46	42	47	TCRBV07,TCRBV11													CASSLNSQPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCCCWSSSAMWCAKCTGTGTACTTCTGTGCCAGCCGCCGAGCGGAGCTGACAGATACGCAGTATTTTGGCCCA	CASRRAELTDTQYF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	6	5	3	5	5	25	34	44	39	49	TCRBV06,TCRBV12					01,02								CASRRAELTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTATCTAGCGGGGGCTACCAAGAGACCCAGTACTTCGGGCCA	CASSVSSGGYQETQYF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	4	2	0	5	2	26	37	52	42	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVSSGGYQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCGGGCAGGATACCGATACGCAGTATTTTGGCCCA	CASSQAGQDTDTQYF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	45	TCRBV03						TCRBJ02	TCRBJ02-03	01	1	4	4	6	5	5	26	42	51	47	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAGQDTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGACAGGCTCTTAGGGAGCAGTACTTCGGGCCG	CASSPRQALREQYF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	4	7	3	8	26	39	48	42	56		TCRBV03-01,TCRBV03-02												CASSPRQALREQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCCTAGCGGGGAGTAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARSLAGSRNTGELFF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	4	3	1	3	5	26	38	50	41	55		TCRBV20-01,TCRBV20-or09_02												CSARSLAGSRNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCTCCGGGACCTGAAGCTTTCTTTGGACAA	CSASPGPEAFF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	0	7	6	5	0	26	35	-1	40	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPGPEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGATCGGAGGAGACATACGAGGCCCATGAGCAGTTCTTCGGGCCA	CATRSEETYEAHEQFF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	10	1	8	5	15	24	33	43	38	58		TCRBV24-01,TCRBV24-or09_02												CATRSEETYEAHEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTCTTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLFFGANVLTF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	4	10	3	5	1	24	36	43	41	44		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLFFGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD02-01	TCRBJ02-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGCCAGGGAGGAGCAGTATTTTGGCCCA	CASSFAREEQYF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	36	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	1	11	7	1	24	36	49	43	50		TCRBV24-01,TCRBV24-or09_02												CASSFAREEQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTACTCCCCGGACAGGAACTTTAACACTGAAGCTTTCTTTGGACAA	CASSYSPDRNFNTEAFF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	51	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	4	2	3	6	26	43	53	46	59		TCRBV06-05,TCRBV06-06,TCRBV06-09												CASSYSPDRNFNTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGAGTGGGGGATGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	10	0.0012822156686754713		49	TCRBV20						TCRBJ01	TCRBJ01-04	01	3	6	1	0	7	3	26	37	49	44	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCTCCTCGACCGGGTGGGATCACGAGCAGTACTTCGGGCCG	CASSSSTGWDHEQYF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	45	unresolved						TCRBJ02	TCRBJ02-07	01	4	0	8	5	12	2	18	31	47	43	49	TCRBV03,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSTGWDHEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TTCTCAGTGACTCKGSCKTSTATSTCTGTGCCAGCAGCCCCACCGACAGAGACCCCTATGGCTACACCTTCGGTTCG	CASSPTDRDPYGYTF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	5	4	6	6	18	30	41	36	47	TCRBV11,TCRBV30													CASSPTDRDPYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCTTCGGGACTAGCTCAGAGACCCAGTACTTCGGGCCA	CASSPFGTSSETQYF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	7	4	6	2	18	30	45	36	47	TCRBV07,TCRBV11					01,02								CASSPFGTSSETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGAACAGGGGAAGAACTATGGCTACACCTTCGGTTCG	CASSLEQGKNYGYTF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	2	2	3	3	18	32	42	35	45	TCRBV07,TCRBV11													CASSLEQGKNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCGTGTATSTCTGTGCCAKCAGCTTAGCGACAGGGGTTAATTCACCCCTCCACTTTGGGAAC	CAXSLATGVNSPLHF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	2	6	0	1	18	-1	43	35	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CAXSLATGVNSPLHF+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTKGGKGACTCWGCTGTGTATYTCTGTGCCAGCAGCAAAACAGGGACAAGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	0.0012822156686754713		37	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	6	10	6	1	22	34	46	40	47	TCRBV03,TCRBV07													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGGRGACWCRGCWSTGTATCTCTGYGCCAGCAGCTTAGTGGACAACACTGAAGCTTTCTTTGGACAA	CASSLVDNTEAFF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	39	unresolved						TCRBJ01	TCRBJ01-01	01	1	1	7	2	1	0	22	38	-1	39	43	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVDNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGTTTTCGAGCTAACACTGAAGCTTTCTTTGGACAA	CASSFRANTEAFF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	6	7	2	6	1	22	33	42	39	43	TCRBV07,TCRBV12					01,02								CASSFRANTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCAACAGGACTTCAGCACAGATACGCAGTATTTTGGCCCA	CASSQQDFSTDTQYF	In	VDJ	1	11	0.0014104372355430183	0.0017230576441102756	45	TCRBV12						TCRBJ02	TCRBJ02-03	01	6	3	4	0	3	5	26	37	45	40	50		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQQDFSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTTAATGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFNGNTGELFF	In	VDJ	1	11	0.0014104372355430183	0.0017230576441102756	42	TCRBV12						TCRBJ02	TCRBJ02-02	01	6	0	10	1	7	0	26	37	-1	44	46		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFNGNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGTGGGGGGGCTAACTATGGCTACACCTTCGGTTCG	CATSDCGGANYGYTF	In	VDJ	1	11	0.0014104372355430183	0.0017230576441102756	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	9	0	0	2	0	24	40	-1	42	49		TCRBV24-01,TCRBV24-or09_02												CATSDCGGANYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCGGGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	0.0015386588024105655		38	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	3	3	1	0	26	39	-1	40	45		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGACCGCGCTACACCTTCGGTTCG	CASSLGPRYTF	In	VDJ	1	12	0.0015386588024105655	0.0018796992481203006	33	TCRBV12						TCRBJ01	TCRBJ01-02	01	3	0	7	9	0	3	26	-1	45	40	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPRYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTTGGACAGGGACAAGGTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	0.0015386588024105655		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	3	1	7	26	40	49	41	56	TCRBV12,TCRBV21													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGGGACTATGGCTACACCTTCGGTTCG	CASSRDYGYTF	In	VDJ	1	12	0.0015386588024105655	0.0018796992481203006	33	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	5	3	3	0	0	26	-1	-1	38	42		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCGGAAAGAAATGAAAAACTGTTTTTTGGCAGT	CSARSERNEKLFF	In	VDJ	1	12	0.0015386588024105655	0.0018796992481203006	39	TCRBV20						TCRBJ01	TCRBJ01-04	01	3	1	8	5	3	4	26	37	43	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSERNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCACTACCCACAACAGGGATTATGTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	0.0015386588024105655		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	3	3	5	9	7	24	34	49	43	56		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAGGAACAGTATCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLGTVSVNTEAFF	In	VDJ	1	12	0.0015386588024105655	0.0018796992481203006	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	5	0	2	6	19	35	41	37	47	TCRBV07,TCRBV11													CASSLGTVSVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTCTTCACGGGAACCTACGAGCAGTACTTCGGGCCG	CASSFFTGTYEQYF	In	VDJ	1	12	0.0015386588024105655	0.0018796992481203006	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	3	2	5	1	19	33	43	38	44	TCRBV05,TCRBV11													CASSFFTGTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCTCTCAGGACAGGGATGGACAGCCCTAGCATTTTGGTGAT		Out	VDJ	1	12	0.0015386588024105655		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	14	6	12	23	35	49	41	61	TCRBV09,TCRBV21													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCGGGGGGCGAAGACCCAGTACTTCGGGCCA	CASSRRGAKTQYF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	1	6	2	3	26	39	48	41	51		TCRBV03-01,TCRBV03-02												CASSRRGAKTQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGAGGCTTAGCGGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAQRLSGASYNEQFF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	3	0	9	1	26	34	51	43	52		TCRBV20-01,TCRBV20-or09_02												CSAQRLSGASYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAACAGTTCTCCATGGGCCCCAGCATTTTGGTGAT	CSARGTVLHGPQHF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	5	9	2	10	26	39	45	41	55		TCRBV20-01,TCRBV20-or09_02												CSARGTVLHGPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCAAGTCTCCGGGACAGTCAATGAGCAGTTCTTCGGGCCA	CASSQVSGTVNEQFF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	6	10	1	22	33	50	43	51		TCRBV12-03,TCRBV12-04												CASSQVSGTVNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCAGGAGGCGGCGGAATCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGGGGIANTGELFF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	54	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	10	1	0	4	11	26	37	46	41	57		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPGGGGIANTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTACAGGCAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSVQAGGSGNTIYF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	1	0	8	0	26	37	-1	45	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVQAGGSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCGTAGGGGCGCGAACTGAAGCTTTCTTTGGACAA	CASSSVGARTEAFF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	2	5	4	5	26	39	48	43	53		TCRBV12-03,TCRBV12-04												CASSSVGARTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAATCTGGACAGGGGGCCCGTTACGGGCAGTTCTTCGGGCCA	XASSQSGQGARYGQFF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	0	12	3	9	23	38	52	41	61	TCRBV01,TCRBV04													XASSQSGQGARYGQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTAACAGGGGGCAGGCTTCACCTCTCCACTTTGGGAAC	CASSNRGQASPLHF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	0	16	1	11	24	36	46	37	57	TCRBV06,TCRBV10													CASSNRGQASPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCAGGGTGCCCTTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	0.0017951019361456598		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	4	1	15	26	38	44	39	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAGGGCGATCAGCCCCAGCATTTTGGTGAT	CSASQGDQPQHF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	5	1	2	26	37	43	38	45		TCRBV20-01,TCRBV20-or09_02												CSASQGDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGCCCGGGACAGGACGCTATGGCTACACCTTCGGTTCG	CSVPGTGRYGYTF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	4	4	5	3	26	33	46	38	49		TCRBV20-01,TCRBV20-or09_02												CSVPGTGRYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATCCCCGGGGGGGAGACCCAGTACTTCGGGCCA	CASSIPGGETQYF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	1	5	5	0	24	36	-1	41	48		TCRBV24-01,TCRBV24-or09_02												CASSIPGGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAGTGGGGGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQWGSNTGELFF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	45	unresolved						TCRBJ02	TCRBJ02-02	01	5	6	1	0	4	1	18	30	39	34	40	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQWGSNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCCGGGGTATTGGGACGGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSRGIGTGTSTDTQYF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	0	15	0	19	31	-1	46	52	TCRBV07,TCRBV11					01,02								CASSRGIGTGTSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTCCCCGGGGGGCTAGATGAAAAACTGTTTTTTGGCAGT	CASSFPGGLDEKLFF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	45	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	8	1	6	3	4	19	33	43	36	47		TCRBV05-06,TCRBV05-07												CASSFPGGLDEKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05	TCRBD02-01*01	TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGGCAGGATTGAACACTGAAGCTTTCTTTGGACAA	CSASWAGLNTEAFF	In	VDJ	1	15	0.0019233235030132068	0.002349624060150376	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	0	5	2	26	37	46	42	48		TCRBV20-01,TCRBV20-or09_02												CSASWAGLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTACTTCCTGGGACAACCTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	0.0019233235030132068		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	1	7	4	24	36	49	43	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCRGCYRTGTATYTYTGTGCTAGCAGCTTAGGACTAGCGGGGGCAGATACGCAGTATTTTGGCCCA	CASSLGLAGADTQYF	In	VDJ	1	16	0.002051545069880754	0.002506265664160401	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	1	2	4	7	0	26	34	-1	41	54	TCRBV11,TCRBV12													CASSLGLAGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGAATGGGTCTTCTCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	0.002179766636748301		43	TCRBV03						TCRBJ02	TCRBJ02-05	01	5	0	9	5	5	8	26	38	46	43	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTGGGGACAAAAGGGTTCACCCCTCCACTTTGGGAAC	CASSWGQKGSPLHF	In	VDJ	1	18	0.002307988203615848	0.002819548872180451	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	6	9	3	6	26	37	46	40	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSWGQKGSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGCGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSFAGAYNEQFF	In	VDJ	1	18	0.002307988203615848	0.002819548872180451	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	2	2	1	0	26	40	-1	41	48		TCRBV12-03,TCRBV12-04												CASSFAGAYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAATGGGGATAACAAACTATGGCTACACCTTCGGTTCG	CASSEMGITNYGYTF	In	VDJ	1	18	0.002307988203615848	0.002819548872180451	45	TCRBV06						TCRBJ01	TCRBJ01-02	01	2	0	8	2	3	5	23	38	45	41	50		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEMGITNYGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06		TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCCAGGGTCTAGCGGGGGGGCCCGGCGGGGAGCTGTTTTTTGGAGAA	CASSQGLAGGPGGELFF	In	VDJ	1	18	0.002307988203615848	0.002819548872180451	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	4	0	7	7	5	20	31	50	38	55	TCRBV11,TCRBV23													CASSQGLAGGPGGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCRGCCSTSTATCTCYGTGCCAGCAGCTTTGTGGCCCTGTACAATGAGCAGTTCTTCGGGCCA	XASSFVALYNEQFF	In	VDJ	1	18	0.002307988203615848	0.002819548872180451	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	9	0	4	3	4	19	33	39	36	43	TCRBV05,TCRBV07													XASSFVALYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAACGACGGCCCCAATGAGCAGTTCTTCGGGCCA	CSANDGPNEQFF	In	VDJ	1	19	0.0024362097704833953	0.002976190476190476	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	2	7	6	4	5	26	34	41	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANDGPNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCGTGTATGTCTGTGCCAGAATCCACATATAAGTAGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	19	0.0024362097704833953		53				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	9	2	6	5	16	5	18	26	46	42	51	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												X+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGGAAGTGAACACTGAAGCTTTCTTTGGACAA	CASSPREVNTEAFF	In	VDJ	1	20	0.0025644313373509426	0.003132832080200501	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	3	0	2	2	26	39	46	41	48		TCRBV03-01,TCRBV03-02												CASSPREVNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCAGCTTATCGGCGGGGGCTGCTGGCTACACCTTCGGTTCG	CASSLSAGAAGYTF	In	VDJ	1	20	0.0025644313373509426	0.003132832080200501	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	7	2	7	3	4	20	35	45	38	49	TCRBV07,TCRBV11													CASSLSAGAAGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATCGGACAGCTCCCTCCAGATACGCAGTATTTTGGCCCA	CSARIGQLPPDTQYF	In	VDJ	1	20	0.0025644313373509426	0.003132832080200501	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	1	5	4	3	7	26	38	47	41	54		TCRBV20-01,TCRBV20-or09_02												CSARIGQLPPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGGCCCCGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	0.0025644313373509426		43	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	9	0	1	3	4	26	40	46	43	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCGGGACAGGGGAAACCCTACGAGCAGTACTTCGGGCCG	CSARPGQGKPYEQYF	In	VDJ	1	20	0.0025644313373509426	0.003132832080200501	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	2	3	4	26	37	50	40	54		TCRBV20-01,TCRBV20-or09_02												CSARPGQGKPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCCCGGGACAGGGAGCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	0.0025644313373509426		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	8	2	4	18	30	41	32	45	TCRBV03,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGTGGGAACCGCGAATGAAAAACTGTTTTTTGGCAGT	CASSLVGTANEKLFF	In	VDJ	1	20	0.0025644313373509426	0.003132832080200501	45	unresolved						TCRBJ01	TCRBJ01-04	01	3	0	8	5	3	6	18	32	39	35	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGTANEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGCAATAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	21	0.0026926529042184894		37	TCRBV24						TCRBJ02	TCRBJ02-04	01	9	4	6	0	2	2	24	33	37	35	39		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-04	TCRBV24		TCRBJ02-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAAGGGACAGGGTTCGGGGAGCTGTTTTTTGGAGAA	CASSEGTGFGELFF	In	VDJ	1	22	0.0028208744710860366	0.003446115288220551	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	1	3	7	0	2	26	-1	50	42	52		TCRBV03-01,TCRBV03-02												CASSEGTGFGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTCGACTGACCTACGAGCAGTACTTCGGGCCG	CASSRLTYEQYF	In	VDJ	1	24	0.003077317604821131	0.0037593984962406013	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	10	2	1	2	26	38	43	39	45	TCRBV12,TCRBV21					01,02								CASSRLTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCGGGGCACTCCTACGAGCAGTACTTCGGGCCG	CSAREAGHSYEQYF	In	VDJ	1	24	0.003077317604821131	0.0037593984962406013	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	3	0	1	2	26	40	47	41	49		TCRBV20-01,TCRBV20-or09_02												CSAREAGHSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGAGCATTCAGGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	24	0.003077317604821131		44	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	4	3	7	6	0	19	34	-1	40	45		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-06	TCRBV05	TCRBD01-01*01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGACATAAGGGGGACTGAAGCTTTCTTTGGACAA	CASSEDIRGTEAFF	In	VDJ	1	25	0.003205539171688678	0.003916040100250626	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	5	9	0	22	34	-1	43	49		TCRBV12-03,TCRBV12-04												CASSEDIRGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCCCCGGCTTCTCCCGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	0.0035902038722913196		46	unresolved						TCRBJ01	TCRBJ01-02	01	4	9	0	3	5	8	18	31	39	36	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCTTAACGGCCACCTTACAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	28	0.0035902038722913196		50	unresolved						TCRBJ01	TCRBJ01-04	01	4	9	0	0	4	7	22	35	42	39	49	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGAAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSQGEGTGELFF	In	VDJ	1	29	0.0037184254391588664	0.0045426065162907266	42	TCRBV03						TCRBJ02	TCRBJ02-02	01	1	5	3	5	4	0	26	42	-1	46	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGEGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GGGGGACTCRGCYGTGTATSTCTGTGCTAGCAGCTCCCTCGGGACAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSSLGTGGETQYF	In	VDJ	1	29	0.0037184254391588664	0.0045426065162907266	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	1	4	5	0	22	35	-1	40	51	TCRBV07,TCRBV11													CASSSLGTGGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCCGGGTTCTTCACCCCTCCACTTTGGGAAC	CASSQGPGSSPLHF	In	VDJ	1	30	0.0038466470060264137	0.004699248120300752	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	1	8	4	9	3	3	26	42	49	45	52		TCRBV03-01,TCRBV03-02				01,02								CASSQGPGSSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCATTAAATCATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	31	0.003974868572893961		49	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	18	0	26	38	-1	56	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTTCCGGGGTGGGCACAGATACGCAGTATTTTGGCCCA	CASSQVSGVGTDTQYF	In	VDJ	1	32	0.004103090139761508	0.005012531328320802	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	3	1	4	3	26	42	51	46	54		TCRBV03-01,TCRBV03-02												CASSQVSGVGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGCTAGTCTCCATTTCAATTCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	33	0.004231311706629055		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	4	8	4	2	16	26	38	44	40	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGAGCAAATGAGCAGTTCTTCGGGCCA	CSASRANEQFF	In	VDJ	1	35	0.004487754840364149	0.005482456140350877	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	8	7	0	4	26	-1	40	37	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSASRANEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCTAGCCCAAGAGACCCAGTACTTCGGGCCA	CASSQDLAQETQYF	In	VDJ	1	36	0.004615976407231696	0.005639097744360902	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	7	1	1	0	26	43	-1	44	49		TCRBV03-01,TCRBV03-02				01,02								CASSQDLAQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGGGCAGGGCCTGGAAACACCATATATTTTGGAGAG	CASSLGAGPGNTIYF	In	VDJ	2	37	0.0047441979740992435	0.005795739348370927	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	3	2	3	1	18	34	42	37	43	TCRBV07,TCRBV11													CASSLGAGPGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAGGCCTTACGAGCAGTACTTCGGGCCG	CASSQDRPYEQYF	In	VDJ	2	38	0.004872419540966791	0.005952380952380952	39	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	5	4	4	1	3	26	43	47	44	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GAGGGACTCRGCCRTGTATCTCTRYGCCAGCAGCCAAGAGTGGGCGGGTGAAAAACTGTTTTTTGGCAGT	XASSQEWAGEKLFF	In	VDJ	2	42	0.005385305808436979	0.006578947368421052	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	7	4	7	4	0	22	39	-1	43	48	TCRBV04,TCRBV11					01,02								XASSQEWAGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTCCCCGGGATAATTTCGGAAACACCATATATTTTGGAGAG	CASSPRDNFGNTIYF	In	VDJ	2	45	0.0057699705090396205	0.007048872180451127	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	8	3	4	4	7	24	35	44	39	51	TCRBV12,TCRBV21													CASSPRDNFGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTCACAGGGGGCGCCCCTTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	50	0.006411078343377356		44				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	0	9	1	5	18	31	41	32	46	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTCGGGACAGGGACTACCTACGAGCAGTACTTCGGGCCG	CASSLVGTGTTYEQYF	In	VDJ	2	53	0.0067957430439799975	0.008302005012531328	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	3	2	2	4	26	42	53	44	57		TCRBV12-03,TCRBV12-04												CASSLVGTGTTYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGAGGACTAGCGGAACCTACGAGCAGTACTTCGGGCCG	CSARGRTSGTYEQYF	In	VDJ	2	53	0.0067957430439799975	0.008302005012531328	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	1	5	2	3	2	26	39	52	42	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGRTSGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAATCAGGATGGAGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	56	0.007180407744582639		47	TCRBV12						TCRBJ02	TCRBJ02-03	01	2	4	4	1	2	6	26	41	47	43	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACAGGGGGCTATGGGGCAGATACGCAGTATTTTGGCCCA	CASSQTGGYGADTQYF	In	VDJ	3	65	0.008334401846390564	0.010181704260651629	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	0	4	0	7	26	-1	50	41	57		TCRBV03-01,TCRBV03-02												CASSQTGGYGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGGGGGCAGCGGAGAGACCCAGTACTTCGGGCCA	CASSQGGGSGETQYF	In	VDJ	3	69	0.00884728811386075	0.010808270676691729	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	6	0	4	2	5	26	42	50	44	55		TCRBV03-01,TCRBV03-02												CASSQGGGSGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGTGGAGATCCATTTACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	3	83	0.01064239005000641		52	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	10	2	5	3	16	26	38	45	41	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01*02	TCRBJ01-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCCCAGGGAACAGGGAGTTCAGGGCTACACCTTCGGTTCG		Out	VDJ	4	105	0.013463264521092448		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	3	3	8	7	7	26	29	42	36	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGATGGGGACGGTCGGAGGCAATGAGCAGTTCTTCGGGCCA	CASSQMGTVGGNEQFF	In	VDJ	5	126	0.016155917425310938	0.019736842105263157	48	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	0	7	6	4	9	26	40	49	44	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQMGTVGGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCGAGACTGAATAATGAGCAGTTCTTCGGGCCA	CASSPRLNNEQFF	In	VDJ	1	10	0.0012822156686754713	0.0015664160401002505	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	10	7	3	4	23	36	43	39	47						01,02							Vb 7.1	CASSPRLNNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGACAGGGGCTACGAGCAGTACTTCGGGCCG	YASSQDRGYEQYF	In	VDJ	1	14	0.0017951019361456598	0.0021929824561403508	39	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	3	0	0	22	-1	-1	39	45													Vb 7.1	YASSQDRGYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGGGCAGGACAGGGAAGGGAAGAGACCCAGTACTTCGGGCCA	CASRAGQGREETQYF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	45	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	3	3	4	5	26	37	49	41	54			01,02										Vb 12	CASRAGQGREETQYF+TCRBV10-01+TCRBJ02-05	TCRBV10-01	TCRBD01-01*01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGCCCGGGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	0.002051545069880754		37	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-01	01	6	8	0	1	3	0	26	37	-1	40	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ01-01	TCRBV10-01		TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAAGGGGACGACCAAATACGCAGTATTTTGGCCCA	CASSERGRPNTQYF	In	VDJ	1	11	0.0014104372355430183	0.0017230576441102756	42	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-03	01	2	0	7	7	2	6	24	39	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERGRPNTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01		TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCCCCGGGACAGCTTTTCACCCCTCCACTTTGGGAAC	CAWRPRDSFSPLHF	In	VDJ	1	11	0.0014104372355430183	0.0017230576441102756	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	5	9	5	3	26	37	49	42	52			unresolved										Vb 20	CAWRPRDSFSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAAATGGGGGTAACTAATGAAAAACTGTTTTTTGGCAGT	CAWSEMGVTNEKLFF	In	VDJ	1	12	0.0015386588024105655	0.0018796992481203006	45	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-04	01	1	6	1	1	4	1	26	39	48	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSEMGVTNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02		TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGAAGCCTCCAGGGCTCTGAAGCTTTCTTTGGACAA	CA*SLQGSEAFF	Stop	VDJ	1	15	0.0019233235030132068		36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	6	7	2	26	34	46	41	48													Vb 20	CA*SLQGSEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTCCGACAGGGGGGTACGAGCAGTACTTCGGGCCG	CAWSPPTGGYEQYF	In	VDJ	1	15	0.0019233235030132068	0.002349624060150376	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	1	4	5	1	26	38	52	43	53			unresolved										Vb 20	CAWSPPTGGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCGGGGGGTCCCGGGGAGCTGTTTTTTGGAGAA	CAWSPGGPGELFF	In	VDJ	1	23	0.002949096037953584	0.0036027568922305762	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	1	6	1	2	26	38	46	39	48													Vb 20	CAWSPGGPGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTACAAAACTACGAGCAGTACTTCGGGCCG	CAWSLQNYEQYF	In	VDJ	1	26	0.003333760738556225	0.004072681704260651	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	6	3	2	3	26	38	43	40	46													Vb 20	CAWSLQNYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCGGAGAAACTTGGAAACACCATATATTTTGGAGAG	CASEKLGNTIYF	In	VDJ	2	37	0.0047441979740992435	0.005795739348370927	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	7	10	2	3	1	5	26	33	38	34	43													Vb 20	CASEKLGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGTTAACCATGGGGGAGACCCAGTACTTCGGGCCA	CAWRLTMGETQYF	In	VDJ	2	40	0.005128862674701885	0.006265664160401002	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	3	6	2	5	9	0	26	37	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRLTMGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATGACCGGAGGATACTATGGCTACACCTTCGGTTCG	CAWSMTGGYYGYTF	In	VDJ	2	60	0.007693294012052827	0.009398496240601503	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	10	1	3	6	2	26	38	49	44	51			unresolved										Vb 20	CAWSMTGGYYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCAGCTTTCGGGGGGAAGGTGAAAAACTGTTTTTTGGCAGT	CAWSSFRGEGEKLFF	In	VDJ	4	90	0.011539941018079241	0.014097744360902255	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	1	7	7	4	26	37	51	44	55													Vb 20	CAWSSFRGEGEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGTCCATACGGTTTGTGGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	20	0.0025644313373509426		49	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	8	5	5	6	9	23	34	43	40	52						01,02								X+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD02-01	TCRBJ02-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACCCGGGCCGATCCTACGAGCAGTACTTCGGGCCG	CASSHPGRSYEQYF	In	VDJ	1	22	0.0028208744710860366	0.003446115288220551	42	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	3	8	0	1	3	3	23	37	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPGRSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCAGATAGCTAGGGTTGGGCAGCTGTTTTTTGGAGAA	CATSRDQIARVGQLFF	In	VDJ	1	17	0.002179766636748301	0.002662907268170426	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-02	01	0	5	3	12	10	6	18	35	49	45	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDQIARVGQLFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01		TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGTGGAAACAGGGGGCTTTTGAATGAGCAGTTCTTCGGGCCA	CATSRDRGNRGLLNEQFF	In	VDJ	1	25	0.003205539171688678	0.003916040100250626	54	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	0	7	8	5	18	35	52	43	57														CATSRDRGNRGLLNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCCCGGGGAGTCCAAGAGACCCAGTACTTCGGGCCA	CATSRARGVQETQYF	In	VDJ	1	28	0.0035902038722913196	0.0043859649122807015	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	8	3	1	2	3	18	34	41	36	44						01,02								CATSRARGVQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTCCCCATAAACCCGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	0.0037184254391588664		52	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	5	1	13	0	18	35	-1	48	51						01,02								X+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAAGGGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATSKGTSGANVLTF	In	VDJ	1	34	0.004359533273496602	0.005325814536340852	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-06	01	4	0	7	0	2	0	18	31	-1	33	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSKGTSGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01		TCRBJ02-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGCAAGGAGGGGAACAATCAGCCCCAGCATTTTGGTGAT	CATSRGKEGNNQPQHF	In	VDJ	2	38	0.004872419540966791	0.005952380952380952	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	10	0	3	4	3	18	34	44	38	47														CATSRGKEGNNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATTGTCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSIVANTGELFF	In	VDJ	2	38	0.004872419540966791	0.005952380952380952	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	6	0	4	0	18	31	-1	35	37						01,02								CATSIVANTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAATCCCTAACCCAGGGCAATGAGCAGTTCTTCGGGCCA	CATSRESLTQGNEQFF	In	VDJ	2	57	0.007308629311450186	0.008928571428571428	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	6	10	0	18	35	-1	45	50														CATSRESLTQGNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATACACAACGCACAGATACGCAGTATTTTGGCCCA	CATSRDTQRTDTQYF	In	VDJ	6	144	0.018463905628926785	0.022556390977443608	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	3	6	1	1	4	18	35	39	36	43														CATSRDTQRTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACGCAGCCATGTACCTGTGTGCCACTTCCTAAACCGACAGGGAGTAATGGCTACACCTTCGGTTCG		Out	VDJ	8	196	0.025131427106039234		43	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	2	3	6	10	4	18	26	43	36	47														X+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGTGTTGGCGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSLVLAPQETQYF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	1	9	0	1	4	3	18	34	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVLAPQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTGTGGGGACCCGCACAGATACGCAGTATTTTGGCCCA	CASSSVGTRTDTQYF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	4	0	7	1	5	2	18	31	41	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSVGTRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTTAGGGGGCCGGGACGGAAATGAAAAACTGTTTTTTGGCAGT	CASSPLGGRDGNEKLFF	In	VDJ	1	15	0.0019233235030132068	0.002349624060150376	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	0	5	5	9	18	30	42	35	51														CASSPLGGRDGNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGGACCCACGAATTCACCCCTCCACTTTGGGAAC	CASSRGPTNSPLHF	In	VDJ	1	16	0.002051545069880754	0.002506265664160401	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	5	0	7	7	2	5	18	30	37	32	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGPTNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACTAACGGACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	26	0.003333760738556225		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	1	9	0	0	5	18	-1	38	32	43						01,02								X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTTAGGAGGGGCAGGGCTACAAGAGACCCAGTACTTCGGGCCA	CASSLGGAGLQETQYF	In	VDJ	4	99	0.012693935119887164	0.01550751879699248	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	1	4	3	2	6	3	18	34	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGAGLQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCACCCGCGGACAGCTTAATGAAAAACTGTTTTTTGGCAGT	CATRGQLNEKLFF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	12	1	5	4	7	2	26	31	44	38	46														CATRGQLNEKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGTCGGGGAGAGCGGGGTTACGCAGTATTTTGGCCCA	CASVGESGVTQYF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	6	3	8	8	1	26	36	51	44	52														CASVGESGVTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCTCTTGTAGACAGGGGGCGCGGGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	0.003205539171688678		46	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	8	8	4	26	38	56	46	60														X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGGGTTTAAGAGACACAGGGCGGTGGAGCTTTCTTTGGACAA		Out	VDJ	1	10	0.0012822156686754713		52	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	3	10	13	6	20	37	56	50	62														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCTAATCGGCCAGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	17	0.002179766636748301		44	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-06	01	6	9	0	4	7	2	20	31	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01		TCRBJ02-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTCGGGGGGAGGGATCACCGGGGAGCTGTTTTTTGGAGAA	CASSSGGGITGELFF	In	VDJ	1	18	0.002307988203615848	0.002819548872180451	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	1	4	2	6	20	31	40	33	46						01,02								CASSSGGGITGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCTCCCAGGGGTTAGGCTACACCTTCGGTTCG	CASSPSQGLGYTF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	8	6	3	23	35	47	41	50														CASSPSQGLGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAGACCGGGACAGTTTCTAACTATGGCTACACCTTCGGTTCG	CASSQTGTVSNYGYTF	In	VDJ	1	9	0.001153994101807924	0.0014097744360902255	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	0	6	3	23	35	48	41	51														CASSQTGTVSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGGTGATCAGCCCCAGCATTTTGGTGAT	CASSPGDQPQHF	In	VDJ	1	11	0.0014104372355430183	0.0017230576441102756	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	4	5	1	2	23	35	40	36	42						01,02								CASSPGDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAAAGGTCTGAAGCTTTCTTTGGACAA	CASSYERSEAFF	In	VDJ	1	11	0.0014104372355430183	0.0017230576441102756	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	5	4	6	3	1	23	38	44	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYERSEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGACAAAACCAAGAGACCCAGTACTTCGGGCCA	CASRRQNQETQYF	In	VDJ	1	12	0.0015386588024105655	0.0018796992481203006	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	6	0	2	2	23	34	40	36	42														CASRRQNQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGACGGCGCTATGGCTACACCTTCGGTTCG	CASSGGRRYGYTF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	0	7	4	2	4	23	35	42	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGRRYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCACGGACAGCTTTACAATGAGCAGTTCTTCGGGCCA	CASSYSHGQLYNEQFF	In	VDJ	1	13	0.0016668803692781126	0.0020363408521303257	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	5	4	4	3	23	40	50	44	53														CASSYSHGQLYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGATACAGGGAACTATATAATTCACCCCTCCACTTTGGGAAC	CASSGYRELYNSPLHF	In	VDJ	1	15	0.0019233235030132068	0.002349624060150376	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	3	4	4	5	23	35	45	39	50														CASSGYRELYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCATCAGTCTATGGCTACACCTTCGGTTCG	CASSASVYGYTF	In	VDJ	1	16	0.002051545069880754	0.002506265664160401	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	5	4	4	1	23	35	42	39	43														CASSASVYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGACTGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRLGSGANVLTF	In	VDJ	1	17	0.002179766636748301	0.002662907268170426	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	2	10	0	2	3	23	34	40	36	43						01,02								CASSRLGSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTCTCAGGGGGGACACTGAAGCTTTCTTTGGACAA	CASILRGDTEAFF	In	VDJ	1	20	0.0025644313373509426	0.003132832080200501	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	1	3	4	1	23	33	44	37	45														CASILRGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGACTAGCGGGGGGGCAGTAGATACGCAGTATTTTGGCCCA	CASSPTSGGAVDTQYF	In	VDJ	1	22	0.0028208744710860366	0.003446115288220551	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	2	0	5	2	4	23	35	51	37	55														CASSPTSGGAVDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCTCGGGGGTACATGGCTACACCTTCGGTTCG	CASSGSGVHGYTF	In	VDJ	1	24	0.003077317604821131	0.0037593984962406013	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	6	4	3	23	35	45	39	48														CASSGSGVHGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCTCGGGGTTGGGCTTGCCGATACGCAGTATTTTGGCCCA	CASSYSLGVGLADTQYF	In	VDJ	1	26	0.003333760738556225	0.004072681704260651	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	6	3	11	23	40	48	43	59														CASSYSLGVGLADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGACAGGGGGCGCGTGAGCAGTTCTTCGGGCCA	CASSYSGQGAREQFF	In	VDJ	1	26	0.003333760738556225	0.004072681704260651	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	0	9	0	3	23	-1	52	40	55														CASSYSGQGAREQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGGGAAGGGAGGGACCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	29	0.0037184254391588664		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	7	9	0	2	6	1	23	33	46	39	47														X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAAACTCCGACAGGAACTTCAACACTGAAGCTTTCTTTGGACAA	CASSVNSDRNFNTEAFF	In	VDJ	1	34	0.004359533273496602	0.005325814536340852	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	2	9	6	23	35	50	44	56														CASSVNSDRNFNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAAAAGCCGCATCGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	35	0.004487754840364149		55	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	2	6	5	12	5	23	37	53	49	58														X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGAACTAGCGGGGGGCTTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	36	0.004615976407231696		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	3	1	2	4	3	23	38	54	42	57														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCAAGTGGGGGGCCACTAATCAGCCCCAGCATTTTGGTGAT	CATKWGATNQPQHF	In	VDJ	2	37	0.0047441979740992435	0.005795739348370927	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	10	6	0	4	7	4	23	30	43	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATKWGATNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGATGCAAGGGGACAGCTTAATTCACCCCTCCACTTTGGGAAC	CASRDARGQLNSPLHF	In	VDJ	2	49	0.006282856776509809	0.007675438596491228	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	5	6	9	2	23	34	50	43	52														CASRDARGQLNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATAGGGACTGGCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CAIGTGDSNQPQHF	In	VDJ	3	65	0.008334401846390564	0.010181704260651629	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	10	0	10	0	2	5	23	30	38	32	43						01,02								CAIGTGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGGTCGGGACAAGCCTCTTCCGAGGATTTTGGAGAG	CAIGSGQASSEDF	In	VDJ	3	66	0.00846262341325811	0.010338345864661654	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	0	6	17	7	14	23	30	43	37	57														CAIGSGQASSEDF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCTCTCGGGACAAGACTATGGCTACACCTTCGGTTCG	CASTLSGQDYGYTF	In	VDJ	3	74	0.009488395948198487	0.011591478696741854	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	6	3	7	2	23	33	46	40	48														CASTLSGQDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGCCGATTATGGCTACACCTTCGGTTCG	CASSEADYGYTF	In	VDJ	3	82	0.010514168483138865	0.012844611528822054	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	1	5	0	5	23	-1	39	35	44														CASSEADYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATAGGGGTCTTAGGCGATGAAAAACTGTTTTTTGGCAGT	CASIGVLGDEKLFF	In	VDJ	54	1341	0.17194512116938068	0.2100563909774436	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	5	2	6	1	9	23	33	39	34	48														CASIGVLGDEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTTCCGGGACAAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPSGTKNTGELFF	In	VDJ	1	8	0.001025772534940377	0.0012531328320802004	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	6	1	4	2	24	41	51	45	53													Vb 18	CASSPPSGTKNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCAACTCCCACAGGGGGCAATGAACACTGAAGCTTTCTTTGGACAA	CASSQLPQGAMNTEAFF	In	VDJ	1	12	0.0015386588024105655	0.0018796992481203006	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	0	9	2	24	35	53	44	55													Vb 18	CASSQLPQGAMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGCTTTGCCAGAGACCCAGTACTTCGGGCCA	CASSPALPETQYF	In	VDJ	1	17	0.002179766636748301	0.002662907268170426	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	3	10	0	4	1	6	24	38	41	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPALPETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACAAACTGAAGCTTTCTTTGGACAA	CASSPGQTEAFF	In	VDJ	1	26	0.003333760738556225	0.004072681704260651	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	5	0	1	24	-1	44	38	45													Vb 18	CASSPGQTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCAGGGGAGGACCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	32	0.004103090139761508		46	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	3	4	2	2	1	5	24	38	45	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAGCACAGATACGCAGTATTTTGGCCCA	CASSPPSTDTQYF	In	VJ	2	40	0.005128862674701885	0.006265664160401002	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	0	0	0	0	0	1	24	-1	41	-1	42													Vb 18	CASSPPSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	1573A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				390	319	66	4	0	252	203	44	5	0	7799	6384	1321	94	0	0.165003821	6.40052605	0.140766695	6.85434484				83865	0.0033980764	0.210056394	0.171945125	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:43	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.8179486956543628	MSKCC- Snyder- P01-02		285.0	
